Glenmark clinical trial in Jaipur dragged into controversy, CDSCO to probe allegations Industry-The Economic Times — April 22, 2018 comments off The issue has escalated to a point where even the Central Drugs Standard Control Organisation, India’s apex drug regulatory body, has sent inspectors to probe the matter.
